Specifically, rHSP90α but not rHSP90β treatment acted through an ATPase-independent manner to restore the defective tumorigenicity and metastasis of HSP90α-knockout MDA-MB-231 breast cancer cells [26]. The gene discussed is HSP90AA1; the disease is breast carcinoma.